Bryce P. Portier

2.0k total citations
37 papers, 1.3k citations indexed

About

Bryce P. Portier is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Bryce P. Portier has authored 37 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 19 papers in Oncology and 16 papers in Cancer Research. Recurrent topics in Bryce P. Portier's work include Cancer Genomics and Diagnostics (13 papers), HER2/EGFR in Cancer Research (9 papers) and Lung Cancer Treatments and Mutations (8 papers). Bryce P. Portier is often cited by papers focused on Cancer Genomics and Diagnostics (13 papers), HER2/EGFR in Cancer Research (9 papers) and Lung Cancer Treatments and Mutations (8 papers). Bryce P. Portier collaborates with scholars based in United States, Switzerland and Italy. Bryce P. Portier's co-authors include Raymond R. Tubbs, Giulio Taglialatela, Aaron M. Gruver, Swaminathan P. Iyer, Bhavin Shah, Jun Qi, Sunil Sharma, Kapil N. Bhalla, Santhana G.T. Devaraj and Warren Fiskus and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Biomaterials.

In The Last Decade

Bryce P. Portier

37 papers receiving 1.3k citations

Peers

Bryce P. Portier
Huiying Piao United States
Yanli Su United States
S. Michael Rothenberg United States
Daniel Wai United States
Yiping He China
Janna Paulsson Sweden
Eleonor Olsson Sweden
Alison Cheung Canada
Charles Decraene France
P. Dettmar Germany
Huiying Piao United States
Bryce P. Portier
Citations per year, relative to Bryce P. Portier Bryce P. Portier (= 1×) peers Huiying Piao

Countries citing papers authored by Bryce P. Portier

Since Specialization
Citations

This map shows the geographic impact of Bryce P. Portier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryce P. Portier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryce P. Portier more than expected).

Fields of papers citing papers by Bryce P. Portier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryce P. Portier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryce P. Portier. The network helps show where Bryce P. Portier may publish in the future.

Co-authorship network of co-authors of Bryce P. Portier

This figure shows the co-authorship network connecting the top 25 collaborators of Bryce P. Portier. A scholar is included among the top collaborators of Bryce P. Portier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryce P. Portier. Bryce P. Portier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lott, Robert L., Peter V. Riccelli, Keith A. Wharton, et al.. (2020). Immunohistochemical Validation of Rare Tissues and Antigens With Low Frequency of Occurrence: Recommendations From The Anatomic Pathology Patient Interest Association (APPIA). Applied immunohistochemistry & molecular morphology. 29(5). 327–334. 2 indexed citations
2.
Merker, Jason D., Kelly A. Devereaux, A. John Iafrate, et al.. (2018). Proficiency Testing of Standardized Samples Shows Very High Interlaboratory Agreement for Clinical Next-Generation Sequencing–Based Oncology Assays. Archives of Pathology & Laboratory Medicine. 143(4). 463–471. 20 indexed citations
3.
4.
Hou, Yanjun, Hiroaki Nitta, Lai Wei, et al.. (2017). HER2 intratumoral heterogeneity is independently associated with incomplete response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinoma. Breast Cancer Research and Treatment. 166(2). 447–457. 61 indexed citations
5.
6.
Portier, Bryce P., Dina R. Mody, Michael T. Deavers, et al.. (2015). Next-Generation Sequencing of a Cohort of Pulmonary Large Cell Carcinomas Reclassified by World Health Organization 2015 Criteria. Archives of Pathology & Laboratory Medicine. 140(4). 312–317. 14 indexed citations
7.
Cagle, Philip T., Kirtee Raparia, & Bryce P. Portier. (2015). Emerging Biomarkers in Personalized Therapy of Lung Cancer. Advances in experimental medicine and biology. 890. 25–36. 14 indexed citations
8.
Fiskus, Warren, Sunil Sharma, Jun Qi, et al.. (2014). Highly Active Combination of BRD4 Antagonist and Histone Deacetylase Inhibitor against Human Acute Myelogenous Leukemia Cells. Molecular Cancer Therapeutics. 13(5). 1142–1154. 155 indexed citations
9.
Fiskus, Warren, Sunil Sharma, Jun Qi, et al.. (2014). BET Protein Antagonist JQ1 Is Synergistically Lethal with FLT3 Tyrosine Kinase Inhibitor (TKI) and Overcomes Resistance to FLT3-TKI in AML Cells Expressing FLT-ITD. Molecular Cancer Therapeutics. 13(10). 2315–2327. 112 indexed citations
10.
Minca, Eugen C., Raymond R. Tubbs, Bryce P. Portier, et al.. (2014). Genomic microarray analysis on formalin-fixed paraffin-embedded material for uveal melanoma prognostication. Cancer Genetics. 207(7-8). 306–315. 5 indexed citations
11.
Kanagal‐Shamanna, Rashmi, Bryce P. Portier, Rajesh R. Singh, et al.. (2013). Next-generation sequencing-based multi-gene mutation profiling of solid tumors using fine needle aspiration samples: promises and challenges for routine clinical diagnostics. Modern Pathology. 27(2). 314–327. 158 indexed citations
12.
Wang, Zhen, Bryce P. Portier, Aaron M. Gruver, et al.. (2013). Automated Quantitative RNA in Situ Hybridization for Resolution of Equivocal and Heterogeneous ERBB2 (HER2) Status in Invasive Breast Carcinoma. Journal of Molecular Diagnostics. 15(2). 210–219. 59 indexed citations
13.
Minca, Eugen C., Bryce P. Portier, Zhen Wang, et al.. (2013). ALK Status Testing in Non–Small Cell Lung Carcinoma. Journal of Molecular Diagnostics. 15(3). 341–346. 91 indexed citations
14.
Portier, Bryce P., Zhen Wang, Erinn Downs‐Kelly, et al.. (2012). Delay to formalin fixation ‘cold ischemia time': effect on ERBB2 detection by in-situ hybridization and immunohistochemistry. Modern Pathology. 26(1). 1–9. 63 indexed citations
15.
Portier, Bryce P., Aaron M. Gruver, Eugen C. Minca, et al.. (2012). From morphologic to molecular: established and emerging molecular diagnostics for breast carcinoma. New Biotechnology. 29(6). 665–681. 5 indexed citations
16.
Patil, Deepa T., Mary P. Bronner, Bryce P. Portier, et al.. (2012). A Five-marker Panel in a Multiplex PCR Accurately Detects Microsatellite Instability-high Colorectal Tumors Without Control DNA. Diagnostic Molecular Pathology. 21(3). 127–133. 36 indexed citations
17.
Portier, Bryce P. & Giulio Taglialatela. (2006). Bcl-2 Localized at the Nuclear Compartment Induces Apoptosis after Transient Overexpression. Journal of Biological Chemistry. 281(52). 40493–40502. 48 indexed citations
18.
Portier, Bryce P., Diana C. Ferrari, & Giulio Taglialatela. (2006). Rapid assay for quantitative measurement of apoptosis in cultured cells and brain tissue. Journal of Neuroscience Methods. 155(1). 134–142. 3 indexed citations
19.
Massaad, Charbel, Bryce P. Portier, & Giulio Taglialatela. (2004). Inhibition of Transcription Factor Activity by Nuclear Compartment-associated Bcl-2. Journal of Biological Chemistry. 279(52). 54470–54478. 39 indexed citations
20.
Peters, N. Kent, Justin S. Smith, Issei Tachibana, et al.. (1999). The human glia maturation factor-gamma gene: genomic structure and mutation analysis in gliomas with chromosome 19q loss. Neurogenetics. 2(3). 163–166. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huiying Piao Breakdown of academic impact, for papers by Yanli Su Breakdown of academic impact, for papers by S. Michael Rothenberg Breakdown of academic impact, for papers by Daniel Wai Breakdown of academic impact, for papers by Yiping He Breakdown of academic impact, for papers by Janna Paulsson Breakdown of academic impact, for papers by Eleonor Olsson Breakdown of academic impact, for papers by Alison Cheung Breakdown of academic impact, for papers by Charles Decraene Breakdown of academic impact, for papers by P. Dettmar
Rankless by CCL
2026